<cite index="1-1">Refex Life Sciences acquires 100% of Modepro India, transitioning from Kavalam family founding promoters to new corporate management</cite>

M&A / JV 21 Aug 2026 · Completed· ✓ Verified

Refex Life Sciences has acquired 100% of Modepro, transitioning the entity from founding promoters (Kavalam family) to new corporate management. Rajani Associates' role included legal diligence, advising on hiving-off of identified target assets, MIDC Agreements approvals, and transaction documentation. This acquisition strengthens Refex Life Sciences' pharmaceutical value chain, combining RLFC (APIs), Modepro (Advanced Intermediates), and Extrovis (Speciality Formulation CRDMO). Modepro's registered office is in Chembur, Mumbai; its manufacturing facility is strategically located at Kurkumbh MIDC, Pune.

Why it mattersConsolidation of advanced pharma intermediate supply within Refex Life Sciences-aligns Modepro with RLFC (APIs) and Extrovis (speciality CRDMO) to create vertically integrated pharma value chain; hiving-off of identified assets and MIDC approvals indicate asset segregation or facility carve-out issues likely tied to Maharashtra industrial park compliance.
CounselRajani Associates
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals